207 related articles for article (PubMed ID: 22831888)
1. Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting.
Green MS; Green P; Malayaman SN; Hepler M; Neubert LJ; Horrow JC
Br J Anaesth; 2012 Nov; 109(5):716-22. PubMed ID: 22831888
[TBL] [Abstract][Full Text] [Related]
2. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
[TBL] [Abstract][Full Text] [Related]
4. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial.
Bergese S; Viloria A; Uribe A; Antor A; Fernandez S
Trials; 2012 Aug; 13():130. PubMed ID: 22862827
[TBL] [Abstract][Full Text] [Related]
5. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery.
Diemunsch P; Gan TJ; Philip BK; Girao MJ; Eberhart L; Irwin MG; Pueyo J; Chelly JE; Carides AD; Reiss T; Evans JK; Lawson FC;
Br J Anaesth; 2007 Aug; 99(2):202-11. PubMed ID: 17540667
[TBL] [Abstract][Full Text] [Related]
6. Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens.
Stiff PJ; Fox-Geiman MP; Kiley K; Rychlik K; Parthasarathy M; Fletcher-Gonzalez D; Porter N; Go A; Smith SE; Rodriguez TE
Biol Blood Marrow Transplant; 2013 Jan; 19(1):49-55.e1. PubMed ID: 22863840
[TBL] [Abstract][Full Text] [Related]
7. Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia.
Yoo JH; Kim SI; Chung JW; Jun MR; Han YM; Kim YJ
Korean J Anesthesiol; 2018 Dec; 71(6):440-446. PubMed ID: 29843509
[TBL] [Abstract][Full Text] [Related]
8. Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial.
Moon HY; Baek CW; Choi GJ; Shin HY; Kang H; Jung YH; Woo YC; Kim JY; Park SG
BMC Anesthesiol; 2014; 14():68. PubMed ID: 25165427
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting.
Pergolizzi JV; Philip BK; Leslie JB; Taylor R; Raffa RB
J Clin Anesth; 2012 Jun; 24(4):334-45. PubMed ID: 22608591
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy.
Jung WS; Kim YB; Park HY; Choi WJ; Yang HS
J Anesth; 2013 Jun; 27(3):396-401. PubMed ID: 23224788
[TBL] [Abstract][Full Text] [Related]
11. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic efficacy of combined aprepitant and dexamethasone in patients at high-risk of postoperative nausea and vomiting from epidural fentanyl analgesia.
Kawano H; Matsumoto T; Hamaguchi E; Manabe S; Nakagawa M; Yamada A; Fujimoto M; Tada F
Minerva Anestesiol; 2015 Apr; 81(4):362-8. PubMed ID: 25220550
[TBL] [Abstract][Full Text] [Related]
13. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
14. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis.
Apfel CC; Zhang K; George E; Shi S; Jalota L; Hornuss C; Fero KE; Heidrich F; Pergolizzi JV; Cakmakkaya OS; Kranke P
Clin Ther; 2010 Nov; 32(12):1987-2002. PubMed ID: 21118734
[TBL] [Abstract][Full Text] [Related]
15. Aprepitant in a multimodal approach for prevention of postoperative nausea and vomiting in high-risk patients: is there such a thing as "too many modalities"?
Hache JJ; Vallejo MC; Waters JH; Williams BA
ScientificWorldJournal; 2009 Apr; 9():291-9. PubMed ID: 19412558
[TBL] [Abstract][Full Text] [Related]
16. Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens.
Holder-Murray J; Esper SA; Boisen ML; Gealey J; Meister K; Medich DS; Subramaniam K
Korean J Anesthesiol; 2019 Aug; 72(4):344-350. PubMed ID: 31096730
[TBL] [Abstract][Full Text] [Related]
17. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
18. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
[TBL] [Abstract][Full Text] [Related]
20. Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.
White PF; Tang J; Song D; Coleman JE; Wender RH; Ogunnaike B; Sloninsky A; Kapu R; Shah M; Webb T
Anesth Analg; 2007 Jan; 104(1):92-6. PubMed ID: 17179250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
